Adc Therapeutics Sa (ADCT)

05:14 AM

Millennium Management LLC Decreases Stock Position in ADC Therapeutics SA (NYSE:ADCT) - Defense World

05:14 AM

Jun 06, 2025

Nuveen Asset Management LLC Purchases 22,989 Shares of ADC Therapeutics SA (NYSE:ADCT) - Defense World

Jun 06, 2025

Jun 05, 2025

ADC Therapeutics Approves Key Proposals at Annual Meeting - TipRanks

Jun 05, 2025

Jun 05, 2025

ProShare Advisors LLC Increases Position in ADC Therapeutics SA (NYSE:ADCT) - Defense World

Jun 05, 2025

Jun 04, 2025

Bank of America Corp DE Sells 1,206,696 Shares of ADC Therapeutics SA (NYSE:ADCT) - MarketBeat

Jun 04, 2025

Jun 04, 2025

ADC Therapeutics (ADCT) Shares Decline Amid Market Movement | AD - GuruFocus

Jun 04, 2025

Jun 04, 2025

Adc Therapeutics SA (NYSE: ADCT) Jumps 2.28%, Turning Investors Away - Stocksregister

Jun 04, 2025

Jun 04, 2025

ADC Therapeutics SA (NYSE:ADCT) Stock Position Boosted by Deutsche Bank AG - Defense World

Jun 04, 2025

Jun 03, 2025

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Boosts Stock Position in ADC Therapeutics SA (NYSE:ADCT) - Defense World

Jun 03, 2025

Jun 02, 2025

ADC Pioneer Awards Strategic Stock Options Package to Secure Top Industry Talent - Stock Titan

Jun 02, 2025

Jun 02, 2025

Bank of America Corp DE Has $2.57 Million Position in ADC Therapeutics SA (NYSE:ADCT) - Defense World

Jun 02, 2025

May 30, 2025

Astellas and Evopoint sign ADC licensing deal - Pharmaceutical Technology

May 30, 2025

May 30, 2025

Woodline Partners LP Takes Position in ADC Therapeutics SA (NYSE:ADCT) - MarketBeat

May 30, 2025

May 27, 2025

Shareholders Will Likely Find ADC Therapeutics SA's (NYSE:ADCT) CEO Compensation Acceptable - simplywall.st

May 27, 2025

May 25, 2025

BNP Paribas Financial Markets Takes $1.43 Million Position in ADC Therapeutics SA (NYSE:ADCT) - MarketBeat

May 25, 2025

May 23, 2025

Equities Analysts Set Expectations for ADCT FY2025 Earnings - MarketBeat

May 23, 2025

May 21, 2025

Antibody Drug Conjugates Market will reach 11.5 Billion USD by 2032 - newstrail.com

May 21, 2025

May 20, 2025

ADC Therapeutics signals data catalysts ahead with ZYNLONTA combinations, aims for regulatory milestones through 2025 - MSN

May 20, 2025

May 19, 2025

BNP Paribas Financial Markets Purchases Shares of 716,668 ADC Therapeutics SA (NYSE:ADCT) - Defense World

May 19, 2025

May 19, 2025

FY2025 EPS Estimates for ADCT Increased by Cantor Fitzgerald - Defense World

May 19, 2025

May 19, 2025

Orbimed Advisors LLC Acquires 1,434,650 Shares of ADC Therapeutics SA (NYSE:ADCT) - MarketBeat

May 19, 2025

May 18, 2025

ADC Therapeutics Reports First Quarter 2025 Financial Results and Provides Operational Update - Nasdaq

May 18, 2025

May 17, 2025

Analysts Are Upgrading ADC Therapeutics SA (NYSE:ADCT) After Its Latest Results - simplywall.st

May 17, 2025

May 17, 2025

Royal Bank of Canada Reaffirms “Outperform” Rating for ADC Therapeutics (NYSE:ADCT) - Defense World

May 17, 2025

May 16, 2025

ADC Therapeutics patents new anti-NaPi2b conjugates - BioWorld MedTech

May 16, 2025

May 15, 2025

ADC Therapeutics SA (ADCT) Reports Q1 Loss, Tops Revenue Estimates - MSN

May 15, 2025

May 15, 2025

ADC Therapeutics (ADCT) Receives Reiterated Outperform Rating fr - GuruFocus

May 15, 2025

May 15, 2025

ADC Therapeutics presents new anti-ASCT2 conjugates - BioWorld MedTech

May 15, 2025

May 15, 2025

ADC Therapeutics SA (NYSE:ADCT) Q1 2025 Earnings Call Transcript - MSN

May 15, 2025

May 15, 2025

ADC Therapeutics to Present at Upcoming Investor Conferences - GuruFocus

May 15, 2025

May 15, 2025

ADCT Reveals Promising LOTIS-7 Trial Data for ZYNLONTA | ADCT St - GuruFocus

May 15, 2025

May 15, 2025

ADC Therapeutics ends development of ADCT-602 and unveils latest Zynlonta data - Clinical Trials Arena

May 15, 2025

May 15, 2025

ADC Therapeutics reports high response in lymphoma trial By Investing.com - Investing.com Canada

May 15, 2025

May 14, 2025

ADC Therapeutics Q1 2025 Earnings Call Transcript - MarketBeat

May 14, 2025

May 14, 2025

ADCT stock touches 52-week low at $1.66 amid market challenges - MSN

May 14, 2025

May 14, 2025

ADC Therapeutics stock plunges 36% amid Zynlonta data release - MSN

May 14, 2025

May 14, 2025

ADC Therapeutics SA 2025 Q1ResultsEarnings Call Presentation (NYSE:ADCT) - Seeking Alpha

May 14, 2025

May 14, 2025

ADC Therapeutics SA reports results for the quarter ended March 31Earnings Summary - TradingView

May 14, 2025

May 14, 2025

Transcript : ADC Therapeutics SA, Q1 2025 Earnings Call, May 14, 2025 - marketscreener.com

May 14, 2025

May 14, 2025

ADC Therapeutics Reports First Quarter 2025 Financial Results - TradingView

May 14, 2025

May 14, 2025

ADC Therapeutics Announces Presentation of LOTIS-7 Clinical Trial Data at the European Hematology Association 2025 Congress (EHA2025) and the 18th International Conference on Malignant Lymphoma (ICML) - GuruFocus

May 14, 2025

May 14, 2025

ADC Therapeutics reports high response in lymphoma trial - Investing.com

May 14, 2025

May 14, 2025

ADC Therapeutics Announces Presentation of LOTIS-7 Clinical Trial Data at the European Hematology Association 2025 Congress (EHA2025) and the 18th International Conference on Malignant Lymphoma (ICML) – Company AnnouncementFT.com - Financial Times

May 14, 2025

May 13, 2025

What To Expect From ADC Therapeutics SA (ADCT) Q1 2025 Earnings - GuruFocus

May 13, 2025

May 13, 2025

Wells Fargo & Company MN Increases Stock Holdings in ADC Therapeutics SA (NYSE:ADCT) - Defense World

May 13, 2025